APOE and Stroke: We excluded participants who were lost to follow-up (n = 755), who had missing APOE genotype data (n = 76), who carried the APOE E2/E4 genotype (n = 53), and those with previous MI (n = 146), previous stroke (n = 98) and further missing MI (n = 52) and stroke (n = 64) data alone.